VitamaS.A.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-05-10
Share capital
30 476 100,00 PLN
Registered address
Powsińska 106, 02-903 Warszawa, Poland
Website
vitama.plWebsite active

Financials

The financial statement for 2023 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2022.

Results vs industry

Revenue
This companyUSD 4.29mMedianUSD 782.27kAverageUSD 24.03m
Net profit
This companyUSD 826.50kMedianUSD 7.91kAverageUSD 2.59m
Operating costs
This companyUSD 3.35mMedianUSD 723.93kAverageUSD 19.92m
Assets
This companyUSD 21.39mMedianUSD 800.34kAverageUSD 29.11m

Bank accounts

Was a VAT taxpayer from 2012-09-01 to 2026-08-04. Removed from VAT register

Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)

Debt

6 closed proceedings recorded in KRZ history. Closed proceedings in history

Registration dateProceeding typeStatus
May 31, 2025
Discontinued enforcement proceedings
Closed
Dec 23, 2024
Discontinued enforcement proceedings
Closed
Dec 12, 2024
Discontinued enforcement proceedings
Closed
Sep 5, 2023
Discontinued enforcement proceedings
Closed
Jul 4, 2023
Discontinued enforcement proceedings
Closed

MSiG notices

Publication dateEvent
May 19, 2022Call to creditors

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,396
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$6,195
Regional investment aid
$1.8M

Tenders

No recorded participation in tenders.

Trademarks

Vitama holds 4 active trademarks registered with the Polish Patent Office. 17 marks have expired or were not registered. The first mark was filed in 2013.

MarkProtected until
NASOPRONAL(word)May 25, 2030
AZYPRONAL(word)May 25, 2030
TRANSBUPREMAX(word)Feb 15, 2027
BEHISTEP(word)Dec 24, 2034
VITAMA NATURE–

Authorized Representatives

Marek Kluczny – President of the Management Board

Manner of representation

Each member of the management board acting independently

Supervisory board

Andrzej Kosman – Supervisory Board Member
Ewa Lubicz Nowicka – Supervisory Board Member
Marcin Kaznowski – Supervisory Board Member

Beneficial owners

Person

Subsidiaries

NameStake
Elopharmsp. z o.o.
50%

Competitors

Change history

DateEvent
2024-08-30Address change
2022-11-30Share capital change
2022-09-28Share capital change
2017-02-07Share capital change
2016-11-29Share capital change

FAQ

Last updated: 2026-03-24